Shuya Matsuda

Chuo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Rechallenge of Atezolizumab Plus Bevacizumab Therapy in Patients With Unresectable Hepatocellular Carcinoma.

Rechallenge of Atezolizumab Plus Bevacizumab Therapy in Patients With Unresectable Hepatocellular Carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 21, 2025

The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment.

The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment.

Journal: Internal medicine (Tokyo, Japan)

Published: September 14, 2022

Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis.

Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 22, 2022

Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencing.

Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencing.

Journal: Hepatology communications

Published: November 10, 2021

Spontaneous portosystemic shunt diameter predicts liver function after balloon-occluded retrograde transvenous obliteration.

Spontaneous portosystemic shunt diameter predicts liver function after balloon-occluded retrograde transvenous obliteration.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: September 10, 2021

Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy.

Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy.

Journal: Hepatology communications

Published: February 28, 2021

Role of magnifying endoscopy with narrow-band imaging in the diagnosis of noninvasive gastric neoplasia.

Role of magnifying endoscopy with narrow-band imaging in the diagnosis of noninvasive gastric neoplasia.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: June 30, 2020

Fractionated small cell-free DNA increases possibility to detect cancer-related gene mutations in advanced colorectal cancer.

Fractionated small cell-free DNA increases possibility to detect cancer-related gene mutations in advanced colorectal cancer.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: May 14, 2020

Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy.

Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 13, 2020

Cancer-related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings.

Cancer-related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 27, 2019

HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers.

HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers.

Journal: PloS one

Published: July 30, 2018

Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.

Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 11, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026